Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia

Pediatric patients with hemato-oncological malignancies and neutropenia resulting from chemotherapy have a high risk of acquiring invasive fungal infections. Oral antifungal prophylaxis with azoles, such as fluconazole or itraconazole, is preferentially used in pediatric patients after chemotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Döring, M., Eikemeier, M., Cabanillas Stanchi, K. M., Hartmann, U., Ebinger, M., Schwarze, C.-P., Schulz, A., Handgretinger, R., Müller, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426129/
https://www.ncbi.nlm.nih.gov/pubmed/25680318
http://dx.doi.org/10.1007/s10096-015-2340-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426129/
https://www.ncbi.nlm.nih.gov/pubmed/25680318
http://dx.doi.org/10.1007/s10096-015-2340-y

Ejemplares similares